Streetbeat News

Regulatory

PULM

Halper Sadeh LLC is investigating PULM and ENTO for potential violations of federal securities laws and breaches of fiduciary duties to shareholders.

Portfolio Pulse from

November 14, 2024 | 1:00 pm

HRMY

Levi & Korsinsky has initiated an investigation into Harmony Biosciences Holdings, Inc. for potential violations of federal securities laws, following a report by Scorpion Capital raising concerns about their narcolepsy drug, Wakix.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

COUR

Levi & Korsinsky has initiated an investigation into Coursera, Inc. for potential violations of federal securities laws following disappointing 1Q 2024 financial results and lowered full-year guidance.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

AZN

Levi & Korsinsky has initiated an investigation into AstraZeneca PLC (NASDAQ:AZN) for potential violations of federal securities laws. This follows reports from Yicai about a fraud investigation involving AstraZeneca and several Chinese government agencies, implicating numerous senior executives.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

ABEO

Abeona Therapeutics reported its Q3 2024 financial results and announced that the FDA has accepted its BLA resubmission for pz-cel, a treatment for recessive dystrophic epidermolysis bullosa, with a PDUFA target action date set for April 29, 2025.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

SCWO

374Water Inc. has successfully demonstrated its AirSCWO technology in destroying PFAS-containing AFFF at a commercial scale, highlighting its potential in addressing environmental and health concerns associated with these persistent chemicals.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

NVAX

Levi & Korsinsky has initiated an investigation into Novavax, Inc. for potential securities fraud violations. This follows the FDA's clinical hold on Novavax's combination influenza and Covid-19 shot and its stand-alone influenza vaccine.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

EPIX

Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. for potential securities fraud violations. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

PACS

Bleichmar Fonti & Auld LLP is investigating PACS Group, Inc. for potential violations of federal securities laws. Investors in PACS are encouraged to seek more information.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

SUI

Levi & Korsinsky has initiated an investigation into Sun Communities, Inc. for potential violations of federal securities laws, following a report by Blue Orca Capital.

Portfolio Pulse from

November 14, 2024 | 12:45 pm